JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB208196

Anti-1-methyladenosine (m1A) antibody [EPR-19836-208]

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Recombinant Monoclonal 1-Methyladenosine antibody. Suitable for IP, ELISA, Dot and reacts with Modified Nucleic Acid, Modified Amino Acid samples. Cited in 7 publications.

View Alternative Names

m1A

5 Images
Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
  • IP

Collaborator

Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)

m1A was immunoprecipitated from 20 μg of HeLa (Human cervix adenocarcinoma epithelial cell) polyA+ RNA with 10 μg of ab208196 and 40 μL of Protein G dynabeads per sample (the IP buffer was 50mM Tris-HCl pH 7.4, 150mM NaCl, and 0.1% NP-40). The amount of m1A was quantified relative to the level of G by LC-MS/MS with electrospray ionization and in positive ionization mode, and compared to the level of m6A/G in the same samples. Error bars represent technical replicate injections of the same sample in mass spec.

All lanes:

Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (ab208196)

false

This image is courtesy of Dr Sigrid Nachtergaele, University of Chicago.

ELISA - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
  • ELISA

Supplier Data

ELISA - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)

BSA-conjugated m1A (modified) and A (unmodified) nucleosides were coated onto wells of a 96 well plate. ELISA was performed on 1.0 μg/ml of antigen using ab208196 at a concentration range of 0.005-4.000 μg/ml followed by Goat Anti-Rabbit IgG (H+L) alkaline phosphatase conjugated secondary antibody at 1/2500 dilution.

Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
  • IP

Supplier Data

Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)

The IP was performed in a U-bottom non-adsorbing propylene 96-well plate.

ab208196 (0.2 μg) was coated into Dynabeads® sheep-anti-rabbit IgG (50 μl) for 1h at RT.

Unmodified/modified oligonucleotides (5 μM) were added to samples containing the antibody/bead complexes and incubated with agitation for 1 hour at RT.

After washing, Peroxidase-conjugated Streptavidin was incubated at 1/1000 dilution with agitation for 1 hour at RT.

ECL substrate was then added and the results read in a non-transparent 96-well plate with a digital detector and analyzed using ImageJ.

Lane 1 : Buffer only.

Lane 2 : Modified oligonucleotide (5 μM), 5' Biotin-mN.mN.mN.mN.mN.[m1A].mN.mN.mN.mN.mN 3'

Lane 3 : Unmodified oligonucleotide (5 μM), 5' Biotin-mN.mN.mN.mN.mN.[A]*.mN.mN.mN.mN.mN 3'

N - equimolar mixture of (A/U/G/C)
m - 2'O methyl protection
* - phosphorothioate protection

Blocking buffer and concentration : 5% NFDM/TBST

Dilution buffer and concentration : TBST/0.1% Triton X-100/1 mM EDTA

All lanes:

Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (ab208196)

true

Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
  • Dot

Collaborator

Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)

Dot blot of total RNA using ab208196 at 2 ug/mL. The Amersham Hybond N+ membrane was pre-spotted with 500 250 125 63 and 32 ng/dot of HeLa total RNA and 500ng of an unmodified RNA probe. The membrane was then blocked with 5% BSA in TBS with 0.1% Tween-20. Followed by blotting with anti-m1A ab208196 or ab208196 together with 100uM of free m1A nucleoside in the same blocking solution to inhibit m1A binding. A goat anti-rabbit HRP was used as the secondary antibody at 1 : 5000 dilution. Methylene blue stain was used to verify RNA loading.

This image is courtesy of Dr Sigrid Nachtergaele, University of Chicago.

Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
  • Dot

Lab

Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)

Primary antibody dilution : 1/500

Secondary antibody : Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated

Secondary antibody dilution : 1/20000

Blocking buffer and dilution buffer : AdvanBlockTM Chemi Blocking buffer

Input : HeLa total RNA 0.5 μg per Dot

Competitive nucleosides : m1A m2A m2.2G

Exposure time : 37 seconds

  • Carrier free

    Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR-19836-208

Isotype

IgG

Carrier free

No

Applications

Dot, IP, ELISA

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Has been developed to discriminate between the modified base 1-methyladenosine (m1A) and the unmodified counterpart Adenosine (A).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Modified Amino Acid": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "0.005-4 µg/mL", "ELISA-species-notes": "<p></p>", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "2 µg/mL", "Dot-species-notes": "<p>For RNA Dot blot testing, AdvanBlock-Chemi Blocking solution (R-03726-E10, Advansta) and Hybond-N+ membrane (Amersham RPN303B, GE) are strongly recommended. You can refer to the RNA dot blot protocol <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"/technical-resources/protocols/rna-dot-blot#reagents\" tabindex=\"-1\">here</a>.</p>" }, "Modified Nucleic Acid": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p>Use 0.2 μg.</p>", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "Dot-species-checked": "notRecommended", "Dot-species-dilution-info": "", "Dot-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

1-Methyladenosine (m1A) is a modified nucleoside present in RNA molecules. It serves as an indicator of methylation which is a critical post-transcriptional modification. In terms of alternate names it can also be called m1A and m-1A. The mass of 1-methyladenosine is approximately 267.26 g/mol. This modification is abundant in various types of RNA including tRNA and rRNA where it is expressed in several cellular compartments. It can be detected using laboratory techniques such as dot blotting and understanding its presence can aid in identifying RNA methylation states.
Biological function summary

1-methyladenosine plays a significant role in the stability and function of tRNA and rRNA molecules. This modification influences the proper folding and functionality of these RNA types ensuring accurate translation processes within the ribosome. 1-methyladenosine is part of complex interplay with different enzymes including methyltransferases that catalyze the addition of methyl groups. These enzymes are integral in maintaining the methylation pattern critical for cell homeostasis and function.

Pathways

RNA methylation is closely involved in gene expression regulations and protein synthesis pathways. m1A is important in pathways like the translation initiation process which requires precise RNA modifications for ribosomal function. Proteins such as methyltransferases are linked with m1A through these pathways helping transfer methyl groups to RNA molecules. This process affects downstream biological effects linked to cellular growth and replication.

Aberrations in 1-methyladenosine levels are associated with specific health conditions. Disruptions in m1A levels can relate to certain cancers where methylation patterns are often dysregulated. Connections exist between m1A and proteins like dyskerin which play roles in pseudouridylation and are implicated in cancer progression. Another disorder related to altered m1A is metabolic syndrome where imbalanced RNA modifications can impact metabolic pathways. These associations offer insights into potential therapeutic targets involving RNA methylation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cell & bioscience 14:92 PubMed39004750

2024

mA demethylase Alkbh3 regulates neurogenesis through mA demethylation of Mmp15 mRNA.

Applications

Dot

Species

Rat

Huan Wang,Linjie Xie,Haomin Guo,Lishi Li,Shuwei Chen,Ye Fan,Jingyuan Tian,Liping Xu,Xuejian Kong,Aiguo Xuan

Nucleic acids research 52:2273-2289 PubMed38118002

2023

Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A.

Applications

Dot

Species

Human

Xiang Gu,Ai Zhuang,Jie Yu,Ludi Yang,Shengfang Ge,Jing Ruan,Renbing Jia,Xianqun Fan,Peiwei Chai

Acta pharmaceutica Sinica. B 13:4840-4855 PubMed38045055

2023

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through 1-methyladenosine modification of circCDK17.

Applications

Unspecified application

Species

Unspecified reactive species

Junting Zhang,Yiying Li,Jianchao Zhang,Lu Liu,Yuan Chen,Xusheng Yang,Xueyi Liao,Muhua He,Zihui Jia,Jun Fan,Jin-Song Bian,Xiaowei Nie

Nature communications 13:2165 PubMed35444240

2022

TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhangli Su,Ida Monshaugen,Briana Wilson,Fengbin Wang,Arne Klungland,Rune Ougland,Anindya Dutta

International journal of molecular sciences 22: PubMed34502037

2021

RNA Modifications in Genomic RNA of Influenza A Virus and the Relationship between RNA Modifications and Viral Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Yuki Furuse

RNA biology 17:1116-1124 PubMed32116132

2020

Isolation and initial structure-functional characterization of endogenous tRNA-derived stress-induced RNAs.

Applications

Unspecified application

Species

Unspecified reactive species

Yasutoshi Akiyama,Prakash Kharel,Takaaki Abe,Paul Anderson,Pavel Ivanov

Nature communications 10:5126 PubMed31719534

2019

Antibody cross-reactivity accounts for widespread appearance of mA in 5'UTRs.

Applications

Unspecified application

Species

Human

Anya V Grozhik,Anthony O Olarerin-George,Miriam Sindelar,Xing Li,Steven S Gross,Samie R Jaffrey
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com